12 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.5B | -$286M | 0.0% | 0.0% | — | $2.4B | $105M |
| 2024 | $1.5B | -$370M | 0.0% | 0.0% | — | $3.1B | $145M |
| 2023 | $1.4B | -$294M | 0.0% | 0.0% | — | — | $246M |
| 2022 | $1.3B | -$16M | 0.0% | 0.0% | — | — | $658M |
| 2021 | $1.4B | $175M | 0.0% | 0.0% | — | — | $635M |
| 2020 | $1.6B | -$139M | 0.0% | 0.0% | — | — | $74M |
| 2019 | $1.0B | -$88M | 0.0% | 0.0% | — | — | $37M |
| 2018 | $1.1B | $287M | 0.0% | 0.0% | — | $3.7B | $55M |
| 2017 | $1.1B | $148M | 0.0% | 25.6% | — | — | $31M |
| 2016 | $1.1B | $141M | 0.0% | 28.6% | — | — | $32M |
| 2015 | — | $124M | — | — | — | — | $38M |
| 2014 | — | $159M | — | — | — | — | $28M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $366M | -$43M | 0.0% | 0.0% | — | $2.4B | $122M |
| Dec '25 | $380M | -$21M | 0.0% | 0.0% | — | $2.4B | $105M |
| Sep '25 | $389M | -$164M | 0.0% | 0.0% | — | — | $201M |
| Jun '25 | $383M | -$92M | 0.0% | 0.0% | — | — | $142M |
| Mar '25 | $387M | -$9M | 0.0% | 0.0% | — | — | $303M |
| Dec '24 | $380M | -$87M | 0.0% | 0.0% | — | $3.1B | $145M |
| Sep '24 | $374M | -$99M | 0.0% | 0.0% | — | — | $257M |
| Jun '24 | $371M | -$98M | 0.0% | 0.0% | — | — | $266M |
| Mar '24 | $371M | -$86M | 0.0% | 0.0% | — | — | $207M |
| Dec '23 | $362M | -$103M | 0.0% | 0.0% | — | — | $246M |
| Sep '23 | $357M | -$66M | 0.0% | 0.0% | — | — | $278M |
| Jun '23 | $346M | -$73M | 0.0% | 0.0% | — | — | $338M |
| Mar '23 | $346M | -$53M | 0.0% | 0.0% | — | — | $380M |
| Dec '22 | $337M | -$65M | 0.0% | 0.0% | — | — | $658M |
| Sep '22 | $323M | -$81M | 0.0% | 0.0% | — | — | $691M |
| Jun '22 | $313M | -$109M | 0.0% | 0.0% | — | — | $705M |
| Mar '22 | $311M | $240M | 0.0% | 0.0% | — | — | $732M |
| Dec '21 | $337M | $366M | 0.0% | 0.0% | — | — | $635M |
| Sep '21 | $337M | -$89M | 0.0% | 0.0% | — | — | $795M |
| Jun '21 | $346M | -$34M | 0.0% | 0.0% | — | — | $849M |
How the market has priced DHCNI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, DIVERSIFIED HEALTHCARE TRUST's revenue has declined 1.2% per year. These are computed facts, not advice.
As of FY2025, DIVERSIFIED HEALTHCARE TRUST reported $2.4B of total debt against $105M of cash.
In FY2025, gross margin was —, operating margin —, and net margin -18.6%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.